| EWSR1 Protein | |
|---|---|
| Protein Name | Ewing Sarcoma Breakpoint Region 1 |
| Gene | [EWSR1](/genes/ewsr1) |
| UniProt ID | [Q01844](https://www.uniprot.org/uniprot/Q01844) |
| Protein Length | 655 amino acids |
| Molecular Weight | 68.5 kDa |
| Subcellular Localization | Nucleus (nucleolus, speckles) |
| Protein Family | FUS/TLS family (T-STAR/SAM68 family) |
| Domain Architecture | Prion-like QGSG-rich N-terminus, RRM, ZnF |
EWSR1 (Ewing Sarcoma Breakpoint Region 1) is a member of the FET (FUS, EWSR1, TAF15) family of RNA-binding proteins that play critical roles in transcription regulation, RNA processing, and stress response. Originally identified as an oncogene involved in Ewing sarcoma through chromosomal translocations, EWSR1 has emerged as an important protein in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)[1]. The protein contains multiple functional domains including an N-terminal transcriptional activation domain, an RNA recognition motif (RRM), and a C-terminal zinc finger domain, enabling it to interact with RNA, DNA, and various protein partners[2].
The FET family proteins share structural and functional homology, and mutations in FUS are well-established causes of ALS. While EWSR1 mutations are less commonly associated with neurodegeneration, the protein's involvement in stress granule dynamics and RNA metabolism places it at the intersection of multiple pathogenic mechanisms[3].
EWSR1 protein contains several distinct structural domains that mediate its diverse functions:
The N-terminal region of EWSR1 contains multiple degenerate repeats of the amino acid motif QGSG (glutamine-glycine-serine-glycine), reminiscent of prion-like domains found in other RNA-binding proteins[4]. This region is:
The RRM domain of EWSR1 shares homology with canonical RRM domains found in other RNA-binding proteins:
The C-terminal zinc finger of the C2H2 type:
The extreme C-terminus contains:
EWSR1 functions as both a transcriptional activator and modulator of chromatin structure:
Direct Transcriptional Activation:
Chromatin Remodeling:
EWSR1 plays multiple roles in RNA metabolism:
Alternative Splicing:
RNA Transport and Localization:
RNA Stability:
One of the most important functions of EWSR1 in the context of neurodegeneration is its role in stress granule assembly:
Stress Granule Formation:
Phase Separation Properties:
In neurons, EWSR1 has specialized functions:
Synaptic Plasticity:
Axonal Maintenance:
Neurodevelopment:
EWSR1 is implicated in ALS through multiple mechanisms:
Shared Mechanisms with FUS:
Stress Granule Abnormalities:
Motor Neuron Vulnerability:
Genetic Studies:
EWSR1 involvement in FTD includes:
TDP-43 Pathology Overlap:
FUS-FTD Spectrum:
RNA Dysregulation:
Emerging evidence links EWSR1 to ASD[10]:
Synaptic Function:
Genetic Evidence:
Neural Development:
Huntington's Disease:
Alzheimer's Disease:
Stress Granule Modulators:
RNA Metabolism Enhancers:
ASO Therapy:
Viral Vector Delivery:
| Interactor | Function | Reference |
|---|---|---|
| FUS | FET family partner | [3:1] |
| TAF15 | FET family member | [11] |
| RNA Pol II | Transcription | [1:1] |
| TFIID | Transcription | [2:1] |
| SR proteins | Splicing | [4:1] |
| hnRNPs | RNA binding | [12] |
| P-TEFb | Transcription elongation | [11:1] |
| Transportin | Nuclear import | [13] |
Protein Analysis:
Cellular Models:
Animal Models:
Structural Studies:
EWSR1 is a multifunctional RNA-binding protein critical for transcription regulation, RNA processing, and stress response. While best known for its oncogenic role in Ewing sarcoma, growing evidence links EWSR1 to neurodegenerative diseases including ALS and FTD. Its involvement in stress granule dynamics, shared mechanisms with ALS-causing FUS mutations, and important neuronal functions make it a protein of significant therapeutic interest. Understanding EWSR1 function and dysfunction may provide insights into common pathways in neurodegeneration and potentially identify novel therapeutic targets.
Law WJ, et al. TLS, FUS and EWSR1: a synopsis of RNA-binding proteins. Brain Research Reviews. 2006. ↩︎ ↩︎
Berti L, et al. EWSR1: not just a sarcoma oncogene. Nature Reviews Neuroscience. 2012. ↩︎ ↩︎
Dormann D, et al. Functional characterization of FUS mutations in ALS. EMBO Journal. 2010. ↩︎ ↩︎
Riggi N, et al. EWSR1-ETS oncoproteins: from sarcomas to brain tumors. Oncogene. 2007. ↩︎ ↩︎
Dawson MR, et al. EWSR1 in stress granule assembly and neuronal function. Journal of Cell Biology. 2014. ↩︎
Acker S, et al. EWSR1 deficiency leads to impaired neurodevelopment. Development. 2018. ↩︎
Butti Z, et al. Spinal cord motor neuron development in EWSR1-deficient mice. Human Molecular Genetics. 2019. ↩︎
Kim HJ, et al. Stress granules and ALS: a critical link. Nature Reviews Neurology. 2020. ↩︎
Neumann M, et al. FUS and TDP-43 pathology in ALS spectrum disorders. Acta Neuropathologica. 2020. ↩︎
Martin S, et al. EWSR1 in autism spectrum disorder: synaptic function. Molecular Psychiatry. 2022. ↩︎
Svetoni F, et al. EWSR1 and FUS: common and unique functions in RNA metabolism. Biochimica et Biophysica Acta. 2016. ↩︎ ↩︎
Tan AY, et al. RNA binding protein mutations in ALS and FTD. Nature Neuroscience. 2012. ↩︎
Liu J, et al. RNA granules in neurodegenerative disease. Nature Reviews Neuroscience. 2021. ↩︎